The Phase 2 trial results Published in the New England Journal of Medicine, the Phase 2 trial showed that participants receiving the highest dose of retatrutide (12mg weekly) achieved a mean weight reduction of 24.2% at 48 weeks
Our goal is to help you move past the confusion and toward a routine that feels sustainable and effective
Aghini Lombardi F, Fiore E, Tonacchera M, Antonangeli L, Rago T, Frigeri M et al (2013) The effect of voluntary iodine prophylaxis in a small rural community: the Pescopagano survey 15 years later
95% CI: 0.33 to 0.69) at a median follow-up of nearly 5 years
Cooking oatmeal with bone broth, vegetable stock, or water rather than milk adds savory flavor and reduces the richness that sometimes triggers nausea in GLP-1 users
Static support addresses symptoms rather than root causes